200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 169105-89-9
169105-89-9 | 3,4-Piperidinediol, 5-(hydroxymethyl)-, (3R,4R,5R)-
CAS No: 169105-89-9 Catalog No: AG001YGP MDL No:
Product Description
Catalog Number:
AG001YGP
Chemical Name:
3,4-Piperidinediol, 5-(hydroxymethyl)-, (3R,4R,5R)-
CAS Number:
169105-89-9
Molecular Formula:
C6H13NO3
Molecular Weight:
147.1723
IUPAC Name:
(3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol
InChI:
InChI=1S/C6H13NO3/c8-3-4-1-7-2-5(9)6(4)10/h4-10H,1-3H2/t4-,5-,6-/m1/s1
InChI Key:
QPYJXFZUIJOGNX-HSUXUTPPSA-N
SMILES:
OC[C@H]1CNC[C@H]([C@@H]1O)O
UNII:
G23AP190YS
Properties
Complexity:
109
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
3
Defined Bond Stereocenter Count:
0
Exact Mass:
147.09g/mol
Formal Charge:
0
Heavy Atom Count:
10
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
4
Isotope Atom Count:
0
Molecular Weight:
147.174g/mol
Monoisotopic Mass:
147.09g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
72.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.5
Literature
| Title | Journal |
|---|---|
| Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease. | The Journal of biological chemistry 20120203 |
| Solution and gas-phase H/D exchange of protein-small-molecule complexes: Cex and its inhibitors. | Journal of the American Society for Mass Spectrometry 20120101 |
| Synthesis of new six- and seven-membered 1-N-iminosugars as promising glycosidase inhibitors. | Bioorganic & medicinal chemistry 20111001 |
| An isofagomine analogue with an amidine at the pseudoanomeric position. | Organic letters 20110603 |
| Docking and SAR studies of D- and L-isofagomine isomers as human β-glucocerebrosidase inhibitors. | Bioorganic & medicinal chemistry 20110601 |
| Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher's disease. | Bioorganic & medicinal chemistry letters 20110301 |
| Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity. | Journal of medicinal chemistry 20110224 |
| Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse. | PloS one 20110101 |
| Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. | Biochemistry 20090609 |
| Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells. | Molecular genetics and metabolism 20090401 |
| In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures. | Bioorganic & medicinal chemistry 20080801 |
| Acceleration effect of an allylic hydroxy group on ring-closing enyne metathesis of terminal alkynes: scope, application, and mechanistic insights. | Chemistry (Weinheim an der Bergstrasse, Germany) 20080101 |
| Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase. | Biochemical pharmacology 20070501 |
| Tandem Staudinger-azaWittig mediated ring expansion: rapid access to new isofagomine-tetrahydroxyazepane hybrids. | Chemical communications (Cambridge, England) 20070114 |
| Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention. | Journal of medicinal chemistry 20070111 |
| Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition. | Journal of medicinal chemistry 20060921 |
| Fluorescent glycosidase inhibiting 1,5-dideoxy-1,5-iminoalditols. | Bioorganic & medicinal chemistry letters 20060415 |
| Fluorescently tagged iminoalditol glycosidase inhibitors as novel biological probes and diagnostics. | Bioorganic & medicinal chemistry 20060315 |
| Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia-ischemia in the neonatal rat brain. | Journal of neuroimmunology 20051001 |
| Compartmentation of lactate originating from glycogen and glucose in cultured astrocytes. | Neurochemical research 20051001 |
| Synthesis and kinetic analysis of the N-acetylhexosaminidase inhibitor XylNAc-isofagomine. | The Journal of organic chemistry 20050916 |
| A new route to diverse 1-azasugars from N-Boc-5-hydroxy-3-piperidene as a common building block. | The Journal of organic chemistry 20050624 |
| Synthesis and evaluation of the glycosidase inhibitory activity of 5-hydroxy substituted isofagomine analogues. | Organic & biomolecular chemistry 20050507 |
| Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. | Journal of neuroscience research 20050101 |
| Atomic resolution analyses of the binding of xylobiose-derived deoxynojirimycin and isofagomine to xylanase Xyn10A. | Chemical communications (Cambridge, England) 20040821 |
| Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal beta-hexosaminidases. | Bioorganic & medicinal chemistry 20040301 |
| Iminosugar glycosidase inhibitors: structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to beta-glucosidases. | Journal of the American Chemical Society 20031126 |
| A new access to polyhydroxy piperidines of the azasugar class: synthesis and glycosidase inhibition studies. | Organic & biomolecular chemistry 20031007 |
| Direct observation of the protonation state of an imino sugar glycosidase inhibitor upon binding. | Journal of the American Chemical Society 20030625 |
| A xylobiose-derived isofagomine lactam glycosidase inhibitor binds as its amide tautomer. | Chemical communications (Cambridge, England) 20030421 |
| Distortion of a cellobio-derived isofagomine highlights the potential conformational itinerary of inverting beta-glucosidases. | Chemical communications (Cambridge, England) 20030421 |
| Isofagomine lactams, synthesis and enzyme inhibition. | Organic & biomolecular chemistry 20030121 |
| Design and development of a common synthetic strategy for a variety of 1-N-iminosugars. | Organic letters 20021031 |
| Biochemical and structural assessment of the 1-N-azasugar GalNAc-isofagomine as a potent family 20 beta-N-acetylhexosaminidase inhibitor. | The Journal of biological chemistry 20011109 |
| Efficient synthesis of isofagomine and noeuromycin. | Chemistry (Weinheim an der Bergstrasse, Germany) 20010903 |
| Accurate determination of rate constants of very slow, tight-binding competitive inhibitors by numerical solution of differential equations, independently of precise knowledge of the enzyme concentration. | Analytical biochemistry 20010815 |
| Iminosugars: potential inhibitors of liver glycogen phosphorylase. | Bioorganic & medicinal chemistry 20010301 |
| Slow inhibition of almond beta-glucosidase by azasugars: determination of activation energies for slow binding. | Biochimica et biophysica acta 20010209 |
| Selective fowler reductions: asymmetric total syntheses of isofagomine and other 1-azasugars from methyl nicotinate. | Organic letters 20010125 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.